T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Phreesia
PHR
$780M
| $483M | 0.05% |
7,833,605
+1,165,206
| +17% | +$77.7M |
|
352
RenaissanceRe
RNR
$13.3B
| $480M | 0.05% |
3,445,823
+208,760
| +6% | +$31.6M |
|
353
FIGS
FIGS
$2.47B
| $479M | 0.05% |
13,017,179
+9,459,584
| +266% | +$381M |
|
354
Papa John's
PZZA
$804M
| $473M | 0.04% |
3,721,345
+25,736
| +0.7% | +$3.11M |
|
|
ZNGA
355
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $466M | 0.04% |
61,947,593
-13,428,671
| -18% | -$122M |
|
|
BNY
356
Bank of New York Mellon
BNY
$110B
| $463M | 0.04% |
8,934,589
+2,468,746
| +38% | +$128M |
|
357
Euronet Worldwide
EEFT
$2.78B
| $462M | 0.04% |
3,631,903
+127,292
| +4% | +$16.9M |
|
358
Adobe
ADBE
$108B
| $461M | 0.04% |
800,590
-16,999
| -2% | -$10.7M |
|
359
Armstrong World Industries
AWI
$7.68B
| $461M | 0.04% |
4,824,136
-8,196
| -0.2% | -$859K |
|
360
Element Solutions
ESI
$9.51B
| $455M | 0.04% |
20,998,895
+1,823,100
| +10% | +$41.6M |
|
|
P
361
Everpure Inc
P
$39B
| $455M | 0.04% |
18,078,018
-226,319
| -1% | -$5M |
|
362
EastGroup Properties
EGP
$11B
| $452M | 0.04% |
2,714,851
+13,932
| +0.5% | +$2.42M |
|
363
3M
MMM
$94.2B
| $452M | 0.04% |
3,082,916
-18,965
| -0.6% | -$3.07M |
|
364
Vulcan Materials
VMC
$36B
| $451M | 0.04% |
2,666,732
-66,790
| -2% | -$12M |
|
|
BPMC
365
DELISTED
Blueprint Medicines
BPMC
| $449M | 0.04% |
4,371,828
+109,714
| +3% | +$10.2M |
|
366
Idexx Laboratories
IDXX
$44.7B
| $447M | 0.04% |
718,903
-12,888
| -2% | -$8.66M |
|
367
Verisk Analytics
VRSK
$24.2B
| $447M | 0.04% |
2,229,598
-1,163,914
| -34% | -$225M |
|
368
Northrop Grumman
NOC
$81.6B
| $444M | 0.04% |
1,232,668
-3,904
| -0.3% | -$1.41M |
|
|
SOLN
369
DELISTED
The Southern Company
SOLN
| $443M | 0.04% |
8,791,411
-6,809
| -0.1% | -$357K |
|
370
United Rentals
URI
$69.7B
| $443M | 0.04% |
1,263,078
+407,857
| +48% | +$137M |
|
371
Raymond James Financial
RJF
$34.8B
| $435M | 0.04% |
4,711,712
-856,464
| -15% | -$76.7M |
|
372
Baxter International
BAX
$14B
| $434M | 0.04% |
5,390,603
-93,784
| -2% | -$7.41M |
|
373
Prothena Corp
PRTA
$466M
| $432M | 0.04% |
6,062,629
+239,544
| +4% | +$14.9M |
|
374
Neurocrine Biosciences
NBIX
$15.3B
| $428M | 0.04% |
4,464,285
-564,974
| -11% | -$53.4M |
|
375
CubeSmart
CUBE
$9.4B
| $423M | 0.04% |
8,738,181
-144,440
| -2% | -$7.29M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.